Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun:44:3-8.
doi: 10.1016/j.ijosm.2022.05.004. Epub 2022 May 31.

Adjunctive osteopathic therapy for hospitalized COVID-19 patients: A feasibility-oriented chart review study with matched controls

Affiliations

Adjunctive osteopathic therapy for hospitalized COVID-19 patients: A feasibility-oriented chart review study with matched controls

Robert P Lennon et al. Int J Osteopath Med. 2022 Jun.

Abstract

Background: Osteopathic manipulative treatment (OMT) may improve outcomes during COVID-related respiratory distress - the most common cause of death from novel coronavirus (SARS-CoV-2). Outcomes from OMT treatments of respiratory distress during the COVID-19 pandemic have not been reported.

Objective: Assess adjunctive OMT in hospitalized patients with SARS-CoV-2 and respiratory distress.

Design: Feasibility oriented retrospective observational cohort study.

Setting: COVID-19 (non-ICU) ward in a tertiary academic medical center.

Methods: Inpatients received daily OMT treatments of rib raising, abdominal diaphragm doming, thoracic pump and pedal pump. Primary outcomes were procedural acceptance, satisfaction, side effects, and adverse events. Secondary outcomes were patient-reported clinical change after therapy; number of hospital days; need during hospitalization for high-flow oxygen, C-PAP/BiPAP or intensive care; need for supplementary oxygen at discharge; and discharge disposition.

Participants: Hospitalized adults with SARS-CoV-2 infection and respiratory distress.

Results: OMT (n = 27) and Control (n = 152) groups were similar in demographics and most laboratory studies. 90% of patients accepted OMT and reported high satisfaction (4.26/±0.71 (maximum 5)), few negative effects, no adverse events, and positive clinical change (5.07 ± 0.96 (maximum 7)). Although no significant differences were found in secondary outcomes, OMT patients trended towards fewer hospital days than Controls (p = 0.053; Cohen's d = 0.22), a relationship that trended towards correlation with number of co-morbidities (p = 0.068).

Conclusion: Hospitalized patients with respiratory distress and COVID-19 reported acceptance, satisfaction, and greater ease of breathing after a four-part OMT protocol, and appear to have a shorter length of hospitalization. Randomized controlled trials are needed to confirm these results.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patient flow diagram.
Fig. 2
Fig. 2
Relationship between hospital days and number of co-morbidities among OMT and Control patients.

Similar articles

Cited by

References

    1. Wang Y., Wang Y., Chen Y., Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020 doi: 10.1002/jmv.25748. - DOI - PMC - PubMed
    1. Shi S., Qin M., Shen B., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China. JAMA Cardiology. 2020;5(7):802–810. doi: 10.1001/jamacardio.2020.0950. - DOI - PMC - PubMed
    1. Scudellari M. How the pandemic might play out in 2021 and beyond. Nature (London) 2020;584(7819):22–25. doi: 10.1038/d41586-020-02278-5. - DOI - PubMed
    1. Steel A., Sundberg T., Reid R., et al. Osteopathic manipulative treatment: a systematic review and critical appraisal of comparative effectiveness and health economics research. Man Ther. 2016;27:165–175. doi: 10.1016/j.math.2016.10.067. - DOI - PubMed
    1. Cerritelli F., Ginevri L., Messi G., et al. Clinical effectiveness of osteopathic treatment in chronic migraine: 3-Armed randomized controlled trial. Compl Ther Med. 2015;23(2):149–156. doi: 10.1016/j.ctim.2015.01.011. - DOI - PubMed